JP2004217634A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004217634A5 JP2004217634A5 JP2003423896A JP2003423896A JP2004217634A5 JP 2004217634 A5 JP2004217634 A5 JP 2004217634A5 JP 2003423896 A JP2003423896 A JP 2003423896A JP 2003423896 A JP2003423896 A JP 2003423896A JP 2004217634 A5 JP2004217634 A5 JP 2004217634A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- protein
- partial peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 59
- 108090000623 proteins and genes Proteins 0.000 claims 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims 32
- 102000004169 proteins and genes Human genes 0.000 claims 32
- 150000003839 salts Chemical class 0.000 claims 25
- 230000000694 effects Effects 0.000 claims 20
- 206010028980 Neoplasm Diseases 0.000 claims 18
- 201000011510 cancer Diseases 0.000 claims 18
- 102000011787 Histone Methyltransferases Human genes 0.000 claims 16
- 108010036115 Histone Methyltransferases Proteins 0.000 claims 16
- 238000012216 screening Methods 0.000 claims 16
- 239000002157 polynucleotide Substances 0.000 claims 14
- 102000040430 polynucleotide Human genes 0.000 claims 14
- 108091033319 polynucleotide Proteins 0.000 claims 14
- 239000003814 drug Substances 0.000 claims 11
- 238000000034 method Methods 0.000 claims 11
- 229940124597 therapeutic agent Drugs 0.000 claims 11
- 150000001413 amino acids Chemical class 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 8
- 230000006907 apoptotic process Effects 0.000 claims 7
- 239000000032 diagnostic agent Substances 0.000 claims 7
- 229940039227 diagnostic agent Drugs 0.000 claims 7
- 230000000069 prophylactic effect Effects 0.000 claims 7
- 230000002401 inhibitory effect Effects 0.000 claims 6
- 239000002773 nucleotide Substances 0.000 claims 6
- 125000003729 nucleotide group Chemical group 0.000 claims 6
- 102000004190 Enzymes Human genes 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 4
- 108010033040 Histones Proteins 0.000 claims 4
- 102000006947 Histones Human genes 0.000 claims 4
- 230000000692 anti-sense effect Effects 0.000 claims 4
- 230000000295 complement effect Effects 0.000 claims 4
- 239000000411 inducer Substances 0.000 claims 4
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 230000001939 inductive effect Effects 0.000 claims 3
- 230000003449 preventive effect Effects 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003423896A JP2004217634A (ja) | 2002-12-24 | 2003-12-22 | がんの予防・治療剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002373144 | 2002-12-24 | ||
| JP2003423896A JP2004217634A (ja) | 2002-12-24 | 2003-12-22 | がんの予防・治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004217634A JP2004217634A (ja) | 2004-08-05 |
| JP2004217634A5 true JP2004217634A5 (enExample) | 2007-02-01 |
Family
ID=32911037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003423896A Abandoned JP2004217634A (ja) | 2002-12-24 | 2003-12-22 | がんの予防・治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004217634A (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012023622A1 (ja) * | 2010-08-16 | 2012-02-23 | 国立大学法人九州大学 | 腫瘍の検査用試薬及び腫瘍の予防用医薬組成物 |
| PL2614369T3 (pl) * | 2010-09-10 | 2016-08-31 | Epizyme Inc | Sposób określania przydatności inhibitorów ludzkiego ezh2 w leczeniu |
| US11365416B2 (en) * | 2018-04-11 | 2022-06-21 | Ionis Pharmaceuticals, Inc. | Modulators of EZH2 expression |
-
2003
- 2003-12-22 JP JP2003423896A patent/JP2004217634A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7128246B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| Chang et al. | Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2 | |
| ES2306483T3 (es) | Proteina inhibidora de la ruta de señalizacion de wnt. | |
| JP2004536614A5 (enExample) | ||
| JP2006149395A5 (enExample) | ||
| JP2004511201A5 (enExample) | ||
| Lange et al. | New eukaryotic semaphorins with close homology to semaphorins of DNA viruses | |
| JP2012501165A5 (enExample) | ||
| CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
| Takahashi et al. | MacroH2A1. 2 binds the nuclear protein Spop | |
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2004217634A5 (enExample) | ||
| JP2005512558A5 (enExample) | ||
| WO1997044454A3 (en) | Human phospholipase inhibitor | |
| JP2020127419A5 (enExample) | ||
| Park et al. | Molecular cloning and expression analysis of the STAT1 gene from olive flounder, Paralichthys olivaceus | |
| KR20170073585A (ko) | Cd44의 단리된 폴리펩타이드 및 이의 사용 | |
| RU2727013C2 (ru) | Циклические аналоги галанина и пути их применения | |
| GB0300718D0 (en) | Proteins | |
| Ziman et al. | Differential expression of four alternate Pax7 paired box transcripts is influenced by organ-and strain-specific factors in adult mice | |
| JP2008522632A5 (enExample) | ||
| KR20160086864A (ko) | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 | |
| RU2006119452A (ru) | Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение | |
| Tanaka et al. | Amino acid sequence of troponin-I from Akazara scallop striated adductor muscle | |
| WO2008099928A1 (ja) | 蛋白質分解酵素活性を調節する作用を有する胎盤蛋白質及びその関連遺伝子 |